Antimeasles immunoglobulin G for serologic diagnosis of otosclerotic hearing loss

Laryngoscope

Volumn 116, Issue 3, 2006, Pages 488-493

  Karosi, Tamás ^a   Kónya, József ^a   Petkó, Mihály ^a   Szabó, László Z ^b   Pytel, József ^c   Jóri, József ^d   Sziklai, István ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b National Health Center   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Antimeasles IgG; Measles virus; Otosclerosis; RT PCR; Stapes fixation

Indexed keywords

IMMUNOGLOBULIN G; MEASLES ANTIBODY; NUCLEIC ACID; RNA; VIRUS NUCLEOPROTEIN; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; AUDITORY OSSICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEARING LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEASLES VIRUS; OTOSCLEROSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; COMPARATIVE STUDY; CONDUCTION DEAFNESS; DIFFERENTIAL DIAGNOSIS; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MEASLES; MIDDLE AGED; STAPES; VIROLOGY;

ADULT; ANTIBODIES, VIRAL; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEARING LOSS, CONDUCTIVE; HUMANS; IMMUNOGLOBULIN G; MALE; MEASLES; MEASLES VIRUS; MIDDLE AGED; OTOSCLEROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; STAPES;

EID: 33645503683     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000204142.80263.2b     Document Type: Article

References (15)

1. Chole RA, McKenna M. Pathophysiology of otosclerosis. Otol-Neurotol 2001;22:249-257.
2. Nadol JB Jr. Hearing loss. N Engl J Med 1993;329:1092-1102.
3. Shambaugh GE Jr. Sensorineural deafness due to cochlear otospongiosis: pathogenesis, clinical diagnosis, and therapy. Otolaryngol Clin North Am 1978;11:135-154.
4. Iyer V, Gristwood. Histopathology of the stapes in otosclerosis. Pathol 1984;16:30-38.
5. Niedermeyer HP, Arnold W, Schuster M, et al. Persistent measles virus infection and otosclerosis. Ann Otol Rhinol Laryngol 2001;110:897-903.
6. McKenna MJ, Mills BG. Ultrastructural and immunohistochemical evidence of measles virus in active otosclerosis. Acta Otolaryngol (Stockh) Suppl 1990;470:130-140.
7. Karosi T, Kónya J, Szabó LZ, Sziklai I. Measles virus prevalence in otosclerotic stapes footplate samples. Otol Neurotol 2004;25:451-456.
8. Goh JP, Chan LL, Tan T. YMRI of cochlear otosclerosis. Br J Radiol 2002;75:502-505.
9. Shea JJ. Thirty years of stapes surgery. J Laryngol Otol 1988;102:14-19.
10. Shambaugh GE Jr. Fluoride therapy for otosclerosis. Arch Otolaryngol Head Neck Surg 1990;116:1217.
11. Lolov SR, Encheva VI, Kyurchiev SD, et al. Antimeasles immunglobulin G in sera of patients with otosclerosis is lower than that in healthy people. Otol Neurotol 2001;22:766-770.
12. Lolov SR, Zarzalanova P, Edrev G, Kyurkchiev S. Decreased measles virus-neutralizing activity in sera from otosclerotic patients. ORL J Otorhinolaryngol Relat Spec 2003;65:279-283.
13. Griffin DE, Ward BJ, Jauregui E, et al. Immune activation in measles. N Engl J Med 1989;320:1667-1672.
14. Norrby E, Oxman MN. Measles virus. In: Fields, BN, Knipe DM, eds. Fields Virology. New York: Raven Press, 1990:1013-1044.
15. Helfgott SM, Mosciscki RA, San Martin J, et al. Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss. Lancet 1991;337:387-389.